TLDR
- JPMorgan elevated IBM to Overweight rating with $291 price objective, raised from $270
- Shares climbed over 4% to approximately $263, bucking broader market weakness
- Software division generates ~45% of total revenue but accounts for nearly two-thirds of overall profit
- Trump issued two executive orders supporting quantum technology, commending IBM’s CEO Arvind Krishna
- Company committed $10 billion toward quantum development over five-year period; Q2 results scheduled for July 22
International Business Machines received a pair of positive developments on Tuesday, driving significant investor interest.
International Business Machines Corporation, IBM
JPMorgan’s Brian Essex elevated IBM stock to Overweight from Neutral and increased his price objective to $291 from $270. Shares surged more than 4% to approximately $263.20, defying a broader market selloff where Nasdaq futures declined 2.66% and S&P 500 futures dropped 1.30%.
Essex’s investment thesis centers on a straightforward premise: IBM’s software segment serves as the profit powerhouse, with its influence expanding. While software represents about 45% of total revenue, it generates nearly two-thirds of the company’s consolidated profits. As artificial intelligence adoption accelerates, Essex anticipates this revenue mix will continue tilting toward software.
To strengthen this strategic pivot, IBM has executed approximately 50 acquisitions during the last five years, including the notable Confluent acquisition in March. While some market observers have raised concerns about the acquisition pace, Essex believes the current heavy investment in software assets will diminish future capital requirements while transitioning IBM toward predictable subscription-based revenue streams.
Essex also highlighted potential valuation expansion if IBM establishes itself as a credible AI infrastructure provider or advances its quantum computing roadmap ahead of schedule.
Presidential Endorsement for Quantum Technology
The analyst upgrade wasn’t IBM’s only positive catalyst. On Monday, President Trump signed a pair of executive orders focused on quantum technology advancement — one requiring development of a research-grade quantum computer by 2028, and another fast-tracking government adoption of post-quantum cryptographic systems by 2031.
IBM’s CEO Arvind Krishna was present at the Oval Office ceremony. Trump subsequently mentioned regretting his early exit from IBM stock holdings. Such high-level public validation carries weight.
Earlier this year, IBM partnered with the Commerce Department to pledge $1 billion toward Anderon, an independent quantum manufacturing facility. IBM subsequently announced an additional $10 billion commitment to quantum research and production capabilities spanning the next five years.
Essex highlighted that IBM has already accumulated over $1.1 billion in quantum customer agreements since 2017 and surpassed $1 billion in total quantum revenue. He views IBM as strategically positioned within what he characterizes as a substantial addressable market opportunity for quantum technologies.
IBM’s internal objective targets delivery of Starling, its most advanced quantum system, by 2029. Essex suggested any acceleration of that timeline “could result in upside” for investors.
What Analysts Are Saying
IBM has accumulated increasingly positive analyst sentiment. Barclays launched coverage earlier this month with a Buy recommendation and $350 price target, while Citigroup maintains a Buy rating with a $375 objective. Wedbush assigns an Outperform rating with a $320 target.
On Monday, IBM announced participation in OpenAI’s Daybreak Cyber Partner Program and introduced a new AI-driven application security platform designed to help enterprises detect and remediate software vulnerabilities more efficiently.
The platform leverages OpenAI’s technology to analyze code, rank high-priority security flaws, and map potential exploit pathways. It extends Project Lightwell, IBM’s $5 billion collaboration with Red Hat targeting software supply chain security challenges.
IBM releases Q2 financial results on July 22. Analyst consensus forecasts earnings per share of $3.00, compared to $2.80 in the year-ago period, with revenue projected at $17.85 billion versus $16.98 billion in the prior-year quarter.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
